Loading...
Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C
OBJECTIVES: To evaluate the impact of 3 treatment regimens upon health-related quality of life and work productivity using patient-reported outcomes (PROs) in chronic hepatitis C infected patients: sofosbuvir (SOF) + daclatasvir (DCV); SOF + DCV + ribavirin (RBV); SOF + simeprevir (SMV). METHODS: 4...
Na minha lista:
| Udgivet i: | Osong Public Health Res Perspect |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korea Centers for Disease Control and Prevention
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935141/ https://ncbi.nlm.nih.gov/pubmed/29740528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.24171/j.phrp.2018.9.2.03 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|